Cleveland Biolabs, Inc. (CBLI) Posts In-Line Q1 Loss of 15c/Share
Tweet
Share
E-mailGet Alerts CBLI Hot Sheet
Price: $3.17 --0%
Financial Fact:
NET INCOME/(LOSS) ATTRIBUTABLE TO CLEVELAND BIOLABS, INC.: 1.14M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
NET INCOME/(LOSS) ATTRIBUTABLE TO CLEVELAND BIOLABS, INC.: 1.14M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Cleveland Biolabs, Inc. (NASDAQ: CBLI) reported Q1 EPS of ($0.15), in-line with the analyst estimate of ($0.15). Revenue for the quarter came in at $931 thousand versus the consensus estimate of $3.5 million.
For earnings history and earnings-related data on Cleveland Biolabs, Inc. (CBLI) click here.
For earnings history and earnings-related data on Cleveland Biolabs, Inc. (CBLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- Cloudastructure reports 164% subscription revenue growth in Q2 2026
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
